Barclays Cuts Sotera Health (NYSE:SHC) Price Target to $21.0

Sotera Health (NYSE:SHC – Get Rating) had its target price decreased by Barclays from $22.00 to $21.00 in a research note issued to investors on Tuesday morning, The Fly reports. Barclays currently has an overweight rating on the stock. Several other research analysts also recently commented on SHC. JPMorgan Chase & Co. raised shares of […]

Related Keywords

United States , Canada , , Barclays , Sotera Health Price Performance , Analyst Recommendations For Sotera Health , Jefferies Financial Group Inc , Wells Fargo Company , Sotera Health , Wolfe Research , Jpmorgan Chase Co , Bridgefront Capital , Sotera Health Company Profile , News Ratings For Sotera Health Daily , Sotera Health Company , Royal Bank , Get Rating , Moderate Buy , Financial Group , Health Company , Nelson Labs , Sotera Health Daily , Nyse Shc , Shc , Medical , Lower Price Target , Barclays Plc ,